noradrenaline (norepinephrine) acid tartrate monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NORADRENALINE BNM noradrenaline (as acid tartrate monohydrate) 4mg/4mL injection concentrated ampoule AUST R: 248512Active ingredients:
noradrenaline (norepinephrine) acid tartrate monohydrate
Dosage form:
Injection, concentrated
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
15 Nov 2024
to
06 Dec 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|
NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 4 mg/4 mL concentrated solution for injection ampoule AUST R: 232700Active ingredients:
noradrenaline (norepinephrine) acid tartrate monohydrate
Dosage form:
Injection, concentrated
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
03 Oct 2024
to
17 Dec 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial AUST R: 183622Active ingredients:
noradrenaline (norepinephrine) acid tartrate monohydrate
Dosage form:
Injection, concentrated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Oct 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|